Insomnia
291 results
210 - 291
Honey for acute cough in children - Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
Effects of opioid, hypnotic and sedating medications on sleep‐disordered breathing in adults with obstructive sleep apnoea
Treating opioid use disorder in primary care—limited data, but looks feasible- Cholinesterase inhibitors for mild cognitive impairment
- Interventions for treating acute high altitude illness: Cochrane systematic review
- Home-based multidimensional survivorship programmes for breast cancer survivors: Cochrane systematic review
- Adrenergic drugs for urinary incontinence in adults: Cochrane systematic review
- Gamma‐hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses
- Smoking cessation
- Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
- Adjuvant treatment to levodopa therapy in Parkinson´s disease patients with motor complications
- Peer support for people with schizophrenia or other serious mental illness
- S‐adenosyl methionine (SAMe) for depression in adults
- Second‐generation antidepressants for preventing seasonal affective disorder in adults
- Impact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer pain
- Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users
- Selective serotonin re‐uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD)
- Antivirals for idiopathic sudden sensorineural hearing loss: Cochrane systematic review
- Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non‐randomised studies
- Depression in adolescents
- Memory complaints, mild cognitive impairment and dementia
- Pharmacological treatment of depression
- Interventions for chronic pruritus of unknown origin
- Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea
- Telerehabilitation for persons with multiple sclerosis
- Aripiprazole versus placebo for schizophrenia: Cochrane systematic review
- Oral budesonide for induction of remission in ulcerative colitis
- Mental disorders due to somatic disease
- Drug therapy for preventing post‐dural puncture headache
- Therapeutic drug monitoring of antiretrovirals for people with HIV
- Laquinimod for multiple sclerosis: Cochrane systematic review
- Acupuncture
- Opioid antagonists with minimal sedation for opioid withdrawal
- Oral budesonide for induction of remission in ulcerative colitis
- Risperidone versus olanzapine for schizophrenia
- Adjuvant therapy with antidepressants for the management of inflammatory bowel disease: Cochrane systematic review
- Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders
- Budesonide for maintenance of remission in Crohn's disease
- Seasonal affective disorder (SAD)
- Oestrogen and combined oestrogen/progestogen replacement therapy for hot flushes
- Short‐course oral steroids as an adjunct therapy for chronic rhinosinusitis
- Ginkgo biloba for tinnitus
- Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome
- Psychosocial interventions for benzodiazepine harmful use, abuse or dependence
- Pharmacotherapy for sleep bruxism
- Green tea (Camellia sinensis) for the prevention of cancer
- Acupuncture for schizophrenia
- Honey for acute cough in children
- Fluvoxamine for the treatment of COVID‐19
- Ganoderma lucidum (Reishi mushroom) for cancer treatment
- Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder
- Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson´s disease patients with motor complications: Cochrane systematic review
- Antidepressants for people with epilepsy and depression
- Systemic and topical antibiotics for chronic rhinosinusitis
- Sound therapy (using amplification devices and/or sound generators) for tinnitus
- Placebo interventions for all clinical conditions: Cochrane systematic review
- Approaches for discontinuation versus continuation of long‐term antidepressant use for depressive and anxiety disorders in adults
- Antidepressants for the treatment of depression in people with cancer
- Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia
- Phosphodiesterase‐4 inhibitors for chronic obstructive pulmonary disease
- Antidepressants plus benzodiazepines for adults with major depression
- Pharmacotherapies for sleep disturbances in dementia
- Intramuscular versus oral corticosteroids to reduce relapses following discharge from the emergency department for acute asthma
- Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non-randomised studies: Cochrane systematic review
- Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C
- Pharmacological intervention for irritability, aggression, and self‐injury in autism spectrum disorder (ASD)
- Lifestyle education in type 2 diabetes
- Neuromodulators for pain management in rheumatoid arthritis
- Varenicline and bupropion and suicidal behaviour
- Functional bowel disorders and the irritable bowel syndrome (IBS)
- Use of medication during pregnancy